NephCure Kidney International ®

Saving Kidneys, Saving Lives

  • Find a Specialist
  • Find a Clinical Trial
  • Donate
  • Living with Kidney Disease
    • Understanding Kidney Disease
    • Understanding Nephrotic Syndrome and Glomerular Disease
    • Treatment Options
    • Managing Your Care
    • Diet and Nutrition
    • Resources A-Z
    • Educational Programs
    • End Stage Renal Disease
    • Just for Kids!
  • Patient Connections
    • Patient Stories
    • Share Your Story
    • NephSpace – Our Online Support Community
    • Patient Support
  • Events
  • Get Involved
    • Join Your Local Community
    • Participate in Research
    • Advocacy
    • Peer Support
    • Donate
  • Research
    • Get Involved in Research
    • Conferences and Meetings
    • Apply for Research Grants
  • About Us
    • Recent News
    • Funded Research
    • Staff
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Partners
  • Donate
    • One Time Donation
    • Give Monthly
    • Donate to an Event

Peter Mundel, M.D.

PeterMundel

Consultant, Third Rock Ventures
Email: pmundel@goldfinchbio.com

Dr. Peter Mundel is a past awardee of the esteemed American Society of Nephrology Young Investigator Award and a distinguished investigator leading the Mundel Laboratory at Massachusetts General Hospital and Harvard Medical School. In April 2014, Dr. Mundel, along with Dr. Anna Greka of Brigham and Women’s Hospital, received a 2014 Top 10 Clinical Research Outstanding Achievement Award from the Clinical Research Forum. In 2013, he and distinguished colleagues published the first targeted treatment for proteinuric kidney disease in the New England Journal of Medicine.

Dr. Mundel attended medical school at the University of Heidelberg in Germany. He completed a postdoctoral research fellowship in the Experimental Kidney and Circulation Research Program at the University of Heidelberg, which was funded by the German Research Foundation. He has authored and co-authored over 86 original research articles. Dr. Mundel’s focus is on the makeup and function of podocytes, key cells found in each of the one million separate filtration units packed into a single human kidney.

Selected Publications

Balbas MD, Burgess MR, Murali R, Wongvipat J, Skaggs BJ, Mundel P, Weins A, Sawyers CL. MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A. 2014 Sep 30.

Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D’Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29.

Greka A, Weins A, Mundel P. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2014 Mar 27; 370(13):1263-6.

Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol. 2014 Feb 15; 306(4):F401-9.

Hakroush S, Cebulla A, Schaldecker T, Behr D, Mundel P, Weins A. Extensive podocyte loss triggers a rapid parietal epithelial cell response. J Am Soc Nephrol. 2014 May; 25(5):927-38.

Buvall L, Rashmi P, Lopez-Rivera E, Andreeva S, Weins A, Wallentin H, Greka A, Mundel P. Proteasomal degradation of Nck1 but not Nck2 regulates RhoA activation and actin dynamics. Nat Commun. 2013; 4:2863.

About Us

  • Financials
  • Board of Directors
  • Scientific Advisory Board
    • Gerald Appel, M.D., Ph.D.
    • Laura Barisoni, M.D.
    • Ross Cagan, Ph.D.
    • Daniel C. Cattran, M.D.
    • Alessia Fornoni, M.D., Ph.D
    • Marilyn Gist Farquhar, Ph.D.
    • Friedhelm Hildebrandt, M.D.
    • Lawrence B. Holzman, M.D.
    • Frederick Kaskel, M.D., Ph.D.
    • Jeffrey B. Kopp, M.D.
    • Matthias Kretzler, M.D.
    • Marva Moxey-Mims, M.D.
    • Peter Mundel, M.D.
    • Martin R. Pollak, M.D.
    • Jochen Reiser, M.D., Ph.D.
    • Andrey S. Shaw, M.D.
    • Karl Tryggvason, M.D., Ph.D.
    • Roger Wiggins, M.B., B.Chir.
    • Michelle P. Winn, M.D.
  • Ambassadors
  • Contact Us
  • Career Opportunities
  • Policy and Disclaimers

Our Mission

NephCure Kidney International’s ® mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome, and to provide education and support that will improve the lives of those affected by these protein-spilling kidney diseases.

Sign up for our emails »

NephCure Kidney International

  • Contact Us
  • Donate
  • Careers
  • Financials
  • Policy and Disclaimers

SHORT ON TIME?

Contact Information

150 S. Warner Road
Suite 402
King of Prussia, PA 19406
1.866 NephCure (637-4287)
info@nephcure.org
EIN: 38-3569922

Follow Us

  • Facebook
  • Twitter

© Copyright 2021 NephCure Kidney International, Inc. All rights reserved worldwide. NephCure Kidney International, and the logo, are federally registered trademarks of NephCure Kidney International, Inc.

Copyright © 2021 · Outreach Pro Theme on Genesis Framework · WordPress · Log in